Related references
Note: Only part of the references are listed.Refractory acquired thrombotic thrombocytopenic purpura treated with caplacizumab in a pediatric patient with systemic lupus erythematosus
Margaret B. Nagel et al.
PEDIATRIC BLOOD & CANCER (2021)
Recognizing and managing hereditary and acquired thrombotic thrombocytopenic purpura in infants and children
Anam Siddiqui et al.
PEDIATRIC BLOOD & CANCER (2021)
Real-world experience with caplacizumab in the management of acute TTP
Tina Dutt et al.
BLOOD (2021)
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine
Hannah Maayan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination
Severine de Bruijn et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura
X. Long Zheng et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Use of caplacizumab in a child with refractory thrombotic thrombocytopenic purpura
Senthil Velan Bhoopalan et al.
PEDIATRIC BLOOD & CANCER (2019)
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
M. Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Pediatric thrombotic thrombocytopenic purpura
Berangere S. Joly et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Flora Peyvandi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
How I treat refractory thrombotic thrombocytopenic purpura
Farzana A. Sayani et al.
BLOOD (2015)
Acute thrombotic thrombocytopenic purpura after pneumococcal vaccination
Yuki Kojima et al.
BLOOD COAGULATION & FIBRINOLYSIS (2014)
Refractory thrombotic thrombocytopenic purpura following influenza vaccination
P. J. Dias et al.
ANAESTHESIA (2009)